Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Extavia, interferon beta-1b
print preview
bookmark
share with colleague
General Information
Company
Novartis AG
Description
Interferon (IFN) beta-1b
Molecular Target
Type I interferon (IFN) receptor
Mechanism of Action
Latest Stage of Development
Marketed
Indication
Multiple sclerosis (MS)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy